Answers are grounded in this paper and cite their sources.
The safety of moxifloxacin is essentially comparable to that of standard therapies for patients receiving the currently registered dosage and for whom contraindications and precautions of use (as in the product label) are taken into account.
No takes yet. Share an insight, caveat, or question.
Tulkens et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: